.
AVEO financial statements
* Numbers in thousands
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
Capitalization * |
526 621 | 331 811 | 85 050 | 49 675 | 56 258 | 42 253 | 319 909 | 213 448 | 79 721 | 169 718 | 80 900 |
EV * |
507 285 | 281 714 | 53 429 | 18 021 | 39 095 | 41 160 | 323 437 | 208 054 | 65 702 | 122 098 | 122 098 |
Stock price $ |
132.6 | 76.5 | 16.7 | 9.5 | 10.1 | 6.1 | 30.2 | 17.7 | 5.2 | 7.93 | 3.78 |
Number of shares * |
3 972 | 4 337 | 5 093 | 5 229 | 5 570 | 6 927 | 10 593 | 12 059 | 15 331 | 21 402 | 21 402 |
EPS |
7,72 | -26,37 | -21,02 | -10,09 | -2,69 | -3,88 | -6,14 | -0,44 | 0,61 | -1,66 | -1,66 |
Revenue * |
164 849 | 19 286 | 1 293 | 18 123 | 19 024 | 2 515 | 7 579 | 5 409 | 28 795 | 6 019 | 6 019 |
Net income * |
30 648 | -114 394 | -107 029 | -52 739 | -15 001 | -26 887 | -65 025 | -5 329 | 9 388 | -35 584 | -35 584 |
Operating profit * |
33 947 | -109 004 | -95 887 | -38 720 | -8 068 | -29 393 | -26 738 | -26 024 | -374 | -38 877 | -38 877 |
Total liabilities * |
71 509 | 88 531 | 76 408 | 50 056 | 23 315 | 29 208 | 90 961 | 55 162 | 35 754 | 31 618 | 31 618 |
Net debt * |
-19 336 | -50 097 | -31 621 | -31 654 | -17 163 | -1 093 | 22 104 | -5 394 | -14 019 | -47 620 | -47 620 |
Total assets * |
295 050 | 207 469 | 146 346 | 70 662 | 40 542 | 27 285 | 50 198 | 27 935 | 50 600 | 66 912 | 66 912 |
Equity * |
223 541 | 118 938 | 69 938 | 20 606 | 17 227 | -1 923 | -40 763 | -27 227 | 14 846 | 35 294 | 35 294 |
Cash and investments * |
221 128 | 160 602 | 118 506 | 52 306 | 34 135 | 23 348 | 33 525 | 24 427 | 47 745 | 61 761 | 61 761 |
Over the past 10 years, the maximum capitalization of AVEO Pharmaceuticals, Inc. is 526 621, the minimum is 42 253. Maximum net income 30 648, Minimum net income -114 394. The maximum price of AVEO shares is 132.6, the minimum price is 5.2.
.
AVEO valuation
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
17,18 | -2,90 | -0,79 | -0,94 | -3,75 | -1,57 | -4,92 | -40,05 | 8,49 | -4,77 | -2,27 |
P/B |
2,36 | 2,79 | 1,22 | 2,41 | 3,27 | -21,97 | -7,85 | -7,84 | 5,37 | 4,81 | 2,29 |
P/S |
3,19 | 17,20 | 65,78 | 2,74 | 2,96 | 16,80 | 42,21 | 39,46 | 2,77 | 28,20 | 13,44 |
E/P |
6% | -34% | -126% | -106% | -27% | -64% | -20% | -3% | 12% | -21% | -44% |
P/FCF |
22,11 | -2,87 | -0,97 | -0,74 | -3,08 | -1,36 | -16,69 | -8,53 | -27,31 | -4,43 | -2,11 |
.
AVEO profitability
Year |
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
ROE |
14% | -96% | -153% | -256% | -87% | 1 398% | 160% | 20% | 63% | -101% | |
ROA |
10% | -55% | -73% | -75% | -37% | -99% | -130% | -19% | 19% | -53% | |
ROIC |
13% | -65% | -83% | -128% | -29% | -174% | -148% | -265% | -1% | -78% |